Found: 28
Select item for more details and to access through your institution.
Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 5, p. 1745, doi. 10.1007/s00277-024-05686-z
- By:
- Publication type:
- Article
Assessing the impact of meropenem exposure on ceftolozane/tazobactam-resistance development in Pseudomonas aeruginosa using in vitro serial passage.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 5, p. 1176, doi. 10.1093/jac/dkae089
- By:
- Publication type:
- Article
Deciphering the Efficacy of β-Lactams in the Face of Metallo-β-Lactamase-Derived Resistance in Enterobacterales: Supraphysiologic Zinc in the Broth Is the Culprit.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 5, p. 1, doi. 10.1093/ofid/ofae228
- By:
- Publication type:
- Article
Assessing the in vivo impact of novel β-lactamase inhibitors on the efficacy of their partner β-lactams against serine carbapenemase-producing Pseudomonas aeruginosa using human-simulated exposures.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 546, doi. 10.1093/jac/dkad412
- By:
- Publication type:
- Article
In vitro activity of cefiderocol against a global collection of carbapenem-resistant Pseudomonas aeruginosa with a high level of carbapenemase diversity.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 2, p. 412, doi. 10.1093/jac/dkad396
- By:
- Publication type:
- Article
Activity of novel β-lactam/β-lactamase inhibitor combinations against serine carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 12, p. 2795, doi. 10.1093/jac/dkad225
- By:
- Publication type:
- Article
In vitro synergy of the combination of sulbactam-durlobactam and cefepime at clinically relevant concentrations against A. baumannii, P. aeruginosa and Enterobacterales.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 12, p. 2801, doi. 10.1093/jac/dkad244
- By:
- Publication type:
- Article
Cefepime in vivo activity against carbapenem-resistant Enterobacterales that test as cefepime susceptible or susceptible-dose dependent in vitro: implications for clinical microbiology laboratory and clinicians.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2242, doi. 10.1093/jac/dkad229
- By:
- Publication type:
- Article
Assessing the in vivo efficacy of rational antibiotics and combinations against difficult-to-treat Pseudomonas aeruginosa producing GES β-lactamases.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 8, p. 1843, doi. 10.1093/jac/dkad098
- By:
- Publication type:
- Article
In vivo efficacy & resistance prevention of cefiderocol in combination with ceftazidime/avibactam, ampicillin/sulbactam or meropenem using human-simulated regimens versus Acinetobacter baumannii.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 4, p. 983, doi. 10.1093/jac/dkad032
- By:
- Publication type:
- Article
Phenotypes, genotypes and breakpoints: an assessment of β-lactam/β-lactamase inhibitor combinations against OXA-48.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 3, p. 636, doi. 10.1093/jac/dkac425
- By:
- Publication type:
- Article
Phenotypic and genotypic profile of ceftolozane/tazobactam-non-susceptible, carbapenem-resistant Pseudomonas aeruginosa.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 1, p. 252, doi. 10.1093/jac/dkac385
- By:
- Publication type:
- Article
Carbapenem-resistant Pseudomonas aeruginosa: an assessment of frequency of isolation from ICU versus non-ICU, phenotypic and genotypic profiles in a multinational population of hospitalized patients.
- Published in:
- Antimicrobial Resistance & Infection Control, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s13756-022-01187-8
- By:
- Publication type:
- Article
Phenotypes, genotypes and breakpoints: an assessment of β-lactam/ β-lactamase inhibitor combinations against OXA-48.
- Published in:
- 2022
- By:
- Publication type:
- journal article
In vivo translational assessment of the GES genotype on the killing profile of ceftazidime, ceftazidime/avibactam and meropenem against Pseudomonas aeruginosa.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Assessment of sustained efficacy and resistance emergence under human-simulated exposure of cefiderocol against Acinetobacter baumannii using in vitro chemostat and in vivo murine infection models.
- Published in:
- JAC-Antimicrobial Resistance, 2022, v. 4, n. 3, p. 1, doi. 10.1093/jacamr/dlac047
- By:
- Publication type:
- Article
Omadacycline pharmacokinetics and soft-tissue penetration in diabetic patients with wound infections and healthy volunteers using in vivo microdialysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Multicenter, Prospective Validation of a Phenotypic Algorithm to Guide Carbapenemase Testing in Carbapenem-Resistant Pseudomonas aeruginosa Using the ERACE-PA Global Surveillance Program.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 2, p. 1, doi. 10.1093/ofid/ofab617
- By:
- Publication type:
- Article
The ERACE-PA Global Surveillance Program: Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosa.
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2021, v. 40, n. 12, p. 2533, doi. 10.1007/s10096-021-04308-0
- By:
- Publication type:
- Article
Discrepancy in sustained efficacy and resistance emergence under human-simulated exposure of cefiderocol against Stenotrophomonas maltophilia between in vitro chemostat and in vivo murine infection models.
- Published in:
- 2021
- By:
- Publication type:
- journal article
High-Dose Daptomycin Is Well Tolerated via 2-Minute IV Push Administration.
- Published in:
- Hospital Pharmacy, 2021, v. 56, n. 4, p. 328, doi. 10.1177/0018578719897076
- By:
- Publication type:
- Article
Cefiderocol Pharmacokinetics in a Patient Receiving Continuous Venovenous Hemodiafiltration.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 7, p. 1, doi. 10.1093/ofid/ofab252
- By:
- Publication type:
- Article
In vivo activity of WCK 4282 (high-dose cefepime/tazobactam) against serine β-lactamase-producing Enterobacterales and Pseudomonas aeruginosa in the neutropenic murine thigh infection model.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy of human-simulated exposures of meropenem/vaborbactam and meropenem against OXA-48 β-lactamase-producing Enterobacterales in the neutropenic murine thigh infection model.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Development and Application of a Pragmatic Algorithm to Guide Definitive Carbapenemase Testing to Identify Carbapenemase-Producing Pseudomonas aeruginosa.
- Published in:
- Antibiotics (2079-6382), 2020, v. 9, n. 11, p. 738, doi. 10.3390/antibiotics9110738
- By:
- Publication type:
- Article
EDTA-modified carbapenem inactivation method (eCIM) for detecting IMP Metallo-β-lactamase–producing Pseudomonas aeruginosa: an assessment of increasing EDTA concentrations.
- Published in:
- BMC Microbiology, 2020, v. 20, n. 1, p. 1, doi. 10.1186/s12866-020-01902-8
- By:
- Publication type:
- Article
Treatment and outcomes of Enterococcus faecium bloodstream infections in solid organ transplant recipients.
- Published in:
- Transplant Infectious Disease, 2020, v. 22, n. 2, p. 1, doi. 10.1111/tid.13251
- By:
- Publication type:
- Article
Cranberry Capsules for Bacteriuria Plus Pyuria in Nursing Home Residents.
- Published in:
- 2017
- By:
- Publication type:
- Letter to the Editor